Clinical Trials Directory

Trials / Completed

CompletedNCT03958903

Investigations of Amygdala Function Using Neurophysiological Recording and Stimulation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to specifically examine the in vivo electrophysiology and effects of direct stimulation of the human amygdala during conditioned and evoked fear. Investigators will also examine amygdala electrophysiology and the effects of stimulation during tasks to examine the effects of reward on fear memory. This study will recruit subjects with a history of temporal lobe epilepsy (TLE) who have undergone neurosurgical implantation with FDA-approved, NeuroPace RNS devices for treatment of seizures. These patients provide a unique cohort with (Responsive Neurostimulation) RNS devices capable of both recording and stimulating the amygdala during performance of fear-based, behavioral tasks.

Conditions

Interventions

TypeNameDescription
DEVICEAmygdala recording and stimulation using Neuropace RNSSubjects will undergo a series of different, fear-related, behavioral tasks while undergoing amygdala electrophysiology recording and stimulation using the Neuropace RNS devices.
BEHAVIORALBehavioral tasksSubjects perform a set of fear related behavioral tasks over 2 days, with 3 tasks each day.In addition to amygdala RNS recording and stimulation, recording of electroencephalography (EEG), electromyography (EMG), and electrodermal activity (EDA) will be performed using standard techniques to capture and quantify the fear response across all tasks.

Timeline

Start date
2019-04-24
Primary completion
2020-03-13
Completion
2020-03-13
First posted
2019-05-22
Last updated
2023-09-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03958903. Inclusion in this directory is not an endorsement.